Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell
Evelina Mazzolari1, Concetta Forino, Sara Guerci
1Divisione di Oncoematologia Pediatrica, Ospedale dei Bambini, Spedali Civili.
Insights
Hematopoietic stem cell transplantation offers long-term survival and good quality of life for infants with severe T-cell immunodeficiency. This study assesses immune reconstitution and clinical status in these patients post-transplant.
Area of Science:
- Immunology
- Pediatric Hematology
- Transplantation Medicine
Background:
- Congenital severe T-cell immunodeficiency (cSTID) is a life-threatening condition.
- Hematopoietic stem cell transplantation (HSCT) is a primary treatment for cSTID, enabling long-term survival.
- Long-term quality of life and immune reconstitution post-HSCT for cSTID require further investigation.
Purpose of the Study:
- To evaluate long-term immune reconstitution in children treated for cSTID.
- To assess the clinical status and quality of life in these patients.
- To identify potential long-term complications following HSCT for cSTID.
Main Methods:
- Analysis of immune function and clinical status in 40 patients with cSTID.
- Patients were alive at least 5 years post-HSCT.
- Data collected on T- and B-cell function, growth parameters, and occurrence of endocrine/neurologic abnormalities.
Main Results:
- The majority of patients achieved normal T- and B-cell function.
- Most patients exhibited normal weight and height at long-term follow-up.
- A minority of patients experienced endocrine (17.5%) or severe neurologic (10%) abnormalities.
Conclusions:
- Current HSCT management strategies lead to long-term survival and good quality of life in most cSTID patients.
- Early diagnosis and prompt HSCT are crucial for favorable long-term outcomes in cSTID.
- HSCT provides excellent perspectives for survival and quality of life in otherwise fatal cSTID disorders.
Background:
Currently, hematopoietic stem cell transplantation allows long-term survival in a high proportion of infants with congenital severe T-cell immunodeficiency. However, relatively little is known of their long-term quality of life.
Objective:
We sought to assess the long-term immune reconstitution and clinical status in children treated with stem cell transplantation for severe T-cell immunodeficiency.
Methods:
Immune function and clinical status have been analyzed in a cohort of 40 patients with severe T-cell immunodeficiency who are alive at a follow-up of at least 5 years after transplantation.
Results:
Most patients have attained normal T- and B-cell function. Weight and height were normal at last follow-up in most patients. Endocrine and severe neurologic abnormalities have been observed in 17.5% and 10% of the patients, respectively.
Conclusions:
These data indicate that with current management strategies, stem cell transplantation can lead to long-term survival and good quality of life in the majority of patients with severe T-cell immunodeficiency.
Clinical Implications:
Prompt recognition of congenital severe T-cell immunodeficiency, followed by stem cell transplantation, allows excellent perspectives of long-term survival and good quality of life for these otherwise fatal disorders.
More Related Videos
Related Concept Videos
Higher Mental Functions of the Brain: Language
Language formation and comprehension take place in the dominant hemisphere. The dominant hemisphere is responsible for understanding the meaning of spoken, written, or sign language, as well as the ability to communicate. For most people, the left hemisphere is the dominant one. The right hemisphere, then, gives tone and emotional context to the...
Cerebral Hemispheres
Lateralization
Language and Cognition
Learning Disabilities
Dyslexia
Dyslexia is a...


